ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Suxinutin®:Pfizer AG
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 
N03AD01 - EthosuximideATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N03 - Antiepileptics
 
N03A - Antiepileptics

This group comprises preparations used in the treatment of epilepsy and related conditions (e.g. seizures).
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

The DDDs for the antiepileptics are based on combination therapy.

N03AD - Succinimide Derivatives
 
N03AD01 - Ethosuximide
DoseRoute of administrationNote
 O 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home